US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist
  • 0.1150
  • -0.0094-7.56%
Close Nov 25 16:00 ET
  • 0.1165
  • +0.0015+1.30%
Post 20:01 ET
6.61MMarket Cap-2P/E (TTM)

About CNS Pharmaceuticals Company

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Company Profile

SymbolCNSP
Company NameCNS Pharmaceuticals
Listing DateNov 8, 2019
Issue Price4.00
Founded2017
CEOMr. John M. Climaco
MarketNASDAQ
Employees5
Fiscal Year Ends12-31
Address2100 West Loop South,Suite 900
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77027
Phone1-800-946-9185
Websitehttp://www.cnspharma.com

Company Executives

  • Name
  • Position
  • Salary
  • John M. Climaco
  • President, Chief Executive Officer and Director
  • 624.35K
  • Dr. Sandra L. Silberman, PhD
  • Chief Medical Officer
  • 270.15K
  • Christopher Downs
  • Chief Financial Officer and Principal Accounting Officer
  • 401.52K
  • Dr. Donald H. Picker, PhD
  • Chief Science Officer
  • --
  • Faith L. Charles
  • Chairman of the Board
  • 112.64K
  • Amy Mahery
  • Independent Director
  • --
  • Bettina M. Cockroft
  • Independent Director
  • 58.31K
  • Jeffry R. Keyes
  • Independent Director
  • 135.46K
  • Carl Evans
  • Independent Director
  • 114.96K
  • Dr. Jerzy Gumulka
  • Independent Director
  • 115.16K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data